Nexgel, INC Form 4 insider transactions

NEXGEL's CEO, Adam R. Levy, sold 4,000 shares of common stock on February 3, 2025, at an average price of $3.6394 per share, as part of a pre-arranged Rule 10b5-1 trading plan for tax planning purposes.

Director Scott Robert Henry sold 3,000 shares of NEXGEL, INC. common stock at an average price of $3.3655 per share under a pre-arranged Rule 10b5-1 trading plan.

NEXGEL CEO Adam Levy reports acquisition of restricted stock units and stock options, along with the sale of common stock under a 10b5-1 trading plan.

Director Scott Robert Henry of NEXGEL, INC. sold 3,000 shares of common stock on December 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

NEXGEL director Scott Robert Henry acquired 1,818 shares of common stock and a warrant to purchase 909 shares in a registered direct offering.

NEXGEL's CEO, Adam R. Levy, acquired 3,636 shares of common stock and a warrant to purchase 1,818 shares in a registered direct offering.

Director Jerome B. Zeldis acquired 3,636 shares of common stock and warrants for 1,818 shares in a registered direct offering by NEXGEL, Inc.

NEXGEL's Chief Financial Officer, Adam Drapczuk III, acquired 17,500 shares of common stock and warrants for 8,750 shares in a registered direct offering.

NEXGEL director Steven Mark Glassman acquired 9,090 shares of common stock and a warrant to purchase 4,545 shares in a registered direct offering.

NEXGEL director John Stein reported a gift of 4,000 shares, a purchase of 3,636 shares, and the acquisition of a warrant to purchase 1,818 shares.

Director Scott Robert Henry acquired stock options for 25,000 shares of NEXGEL, INC. common stock on September 13, 2024.

Director Jerome B. Zeldis acquired 25,000 stock options in NEXGEL, Inc. on September 13, 2024, according to a Form 4 filing.

Director Steven Mark Glassman acquired stock options for 25,000 shares of NEXGEL, INC. common stock on September 13, 2024.

Director John Nachum Stein acquired 25,000 stock options in NEXGEL, INC. on September 13, 2024, according to a Form 4 filing.

Director John Nachum Stein reports acquisition of NEXGEL shares and warrants through a registered direct offering, subject to a 180-day lock-up period.

Steven Mark Glassman, a director of NEXGEL, Inc., acquired 10,000 shares of common stock and a warrant to purchase 5,000 shares in a registered direct offering.

Director Jerome B. Zeldis increased his holdings in NEXGEL, Inc. through a purchase of common stock and warrants as part of a registered direct offering.

Director Scott Robert Henry acquired 10,000 shares of common stock and a warrant to purchase 5,000 shares of common stock in NEXGEL's registered direct offering.

Adam Drapczuk III, CFO of NEXGEL, Inc., reports acquisition of common stock and warrants through a registered direct offering.

Director Scott Robert Henry increased his holdings in NEXGEL, acquiring shares and warrants through a registered direct offering.

Director Steven Mark Glassman acquired 11,848 shares of NEXGEL common stock and warrants to purchase 5,924 shares in a registered direct offering on March 1, 2024.

NEXGEL's CFO, Adam Drapczuk III, reports acquiring common stock and warrants through a registered direct offering, subject to a 180-day lock-up period.